XIV. The pathology of transformation of indolent B cell lymphomas

E-ISSN： 1099-1069|33|S1|75-79

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.33, Iss.S1, 2015-06, pp. : 75-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increasing complexity of high-grade B-cell lymphomas

By Armitage James O. Bociek R. Gregory

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1611-1613

Blackwell Publishing

Access to resources Recommend Favorite

An array of immunotherapeutic strategies for B-cell lymphomas

By Schultze J.L.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2059-2071

Informa Healthcare

Access to resources Recommend Favorite

IX. Is it only about MYC? How to approach the diagnosis of diffuse large B‐cell lymphomas

Hematological Oncology (Electronic), Vol. 33, Iss. S1, 2015-06 ,pp. : 50-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Perspectives on Cytokines for Anti-retroviral Therapy in AIDS Related B-cell Lymphomas

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 2, 2003-06 ,pp. : 137-149

Bentham Science Publishers

Access to resources Recommend Favorite

CD20-positive T-cell Lymphoma with Indolent Clinical Behaviour

By Xiao W-B Wang Z-M Wang L-J

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1170-1174

Field House Publishing

Access to resources Recommend Favorite